Disruption of Tumor Cell Adhesion Promotes Angiogenic Switch and Progression to Micrometastasis in RAF-Driven Murine Lung Cancer

Cancer Cell

Volumn 12, Issue 2, 2007, Pages 145-159

  Ceteci, Fatih ^a   Ceteci, Semra ^a   Karreman, Christiaan ^a   Kramer, Boris W ^b   Asan, Esther ^a   Götz, Rudolf ^a   Rapp, Ulf R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

CELLCYCLE; SIGNALING

Indexed keywords

BETA CATENIN; RAF PROTEIN; UVOMORULIN; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL DISRUPTION; CELL JUNCTION; CONTROLLED STUDY; ENDODERM; GENE EXPRESSION; GENE TARGETING; LUNG CANCER; LUNG NON SMALL CELL CANCER; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; UPREGULATION;

MURINAE;

EID: 34547609385     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.06.014     Document Type: Article

References (48)

1. American Cancer Society. Cancer Facts & Figures 2006 (2006), American Cancer Society, Atlanta
2. Berenblum I. A speculative review: The probable nature of promoting action and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res. 14 (1954) 471-477
3. Berx G., and Van Roy F. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3 (2001) 289-293
4. Birchmeier W. Cell adhesion and signal transduction in cancer. Conference on cadherins, catenins and cancer. EMBO Rep. 6 (2005) 413-417
5. Boussadia O., Kutsch S., Hierholzer A., Delmas V., and Kemler R. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech. Dev. 115 (2002) 53-62
6. Bremnes R.M., Veve R., Hirsch F.R., and Franklin W.A. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36 (2002) 115-124
7. Cavallaro U., and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4 (2004) 118-132
8. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 127 (2006) 469-480
9. Dahl U., Sjödin A., and Semb H. Cadherins regulate aggregation of pancreatic β-cells in vivo. Development 122 (1996) 2895-2902
10. Dequéant M.-L., Glynn E., Gaudenz K., Wahl M., Chen J., Mushegian A., and Pourquie O. A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science 314 (2006) 1595-1598
11. Derksen P.W.B., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., van Beijnum J.R., Griffioen A.W., Vink J., Krimpenfort P., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10 (2006) 437-449
12. Easwaran V., Lee S.H., Inge L., Guo L., Goldbeck C., Garrett E., Wiesmann M., Garcia P.D., Fuller J.H., Chan V., et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 63 (2003) 3145-3153
13. Fedorov L.M., Papadopoulos T., Tyrsin O.Y., Twardzik T., Götz R., and Rapp U.R. Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf. Cancer Res. 62 (2002) 6297-6303
14. Fedorov L.M., Papadopoulos T., Tyrsin O.Y., Twardzik T., Götz R., and Rapp U.R. Loss of p53 in craf induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch. Cancer Res. 63 (2003) 2268-2277
15. Folkman J. Angiogenesis. Annu. Rev. Med. 57 (2006) 1-18
16. Folkman J., Watson K., Ingber D., and Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339 (1989) 58-61
17. Götz R., Kramer B.W., Camarero G., and Rapp U.R. BAG-1 haplo-insufficiency impairs lung tumorigenesis. BMC Cancer 24 (2004) 85
18. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
19. Herzig M., Savarese F., Novatchkova M., Semb H., and Christofori G. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 26 (2007) 2290-2298 10.1038/sj.onc.1210029 Published online October 9, 2006
20. Houben R., Becker J.C., Kappel A., Terheyden P., Brocker E.B., Goetz R., and Rapp U.R. Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J. Carcinog. 3 (2004) 6
21. Huang C., Liu D., Masuya D., Nakashima T., Kameyama K., Ishikawa S., Ueno M., Haba R., and Yokomise H. Clinical application of biological markers for treatments of resectable non-small-cell lung cancers. Br. J. Cancer 92 (2005) 1231-1239
22. Huber M.A., Kraut N., and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17 (2005) 548-558
23. Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., and Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29 (2001) 418-425
24. Kerkhoff E., Fedorov L.M., Siefken R., Walter A.O., Papadopoulus T., and Rapp U.R. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth Differ. 11 (2000) 185-190
25. Kim J.S., Han J., Shim Y.M., Park J., and Kim D.H. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Cancer 104 (2005) 1825-1833
26. Liu D., Huang C., Kameyama K., Hayashi E., Yamauchi A., Kobayashi S., and Yokomise H. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann. Thorac. Surg. 71 (2001) 949-954
27. Maurange C., Lee N., and Paro R. Signaling meets chromatin during tissue regeneration in Drosophila. Curr. Opin. Genet. Dev. 16 (2006) 485-489
28. Mazieres J., He B., You L., Xu Z., Lee A.Y., Mikami I., Reguart N., Rosell R., McCormick F., and Jablons D.M. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 15 (2004) 4717-4720
29. Nakashima T., Huang C., Liu D., Kameyama K., Masuya D., Kobayashi S., Kinoshita M., and Yokomise H. Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Br. J. Cancer 88 (2003) 1727-1733
30. Nakashima T., Huang C.L., Liu D., Kameyama K., Masuya D., Ueno M., Haba R., and Yokomise H. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer. Med. Sci. Monit. 10 (2004) BR157-BR165
31. Nikolopoulos S.N., Blaikie P., Yoshioka T., Guo W., and Giancotti F.G. Integrin β4 signaling promotes tumor angiogenesis. Cancer Cell 6 (2004) 471-483
32. Norton L., and Massaqué J. Is cancer a disease of self-seeding?. Nat. Med. 12 (2006) 875-878
33. Okubo T., and Hogan B.L. Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J. Biol. 3 (2004) 11.1-11.17
34. Perl A.-K., Wilgenbus P., Dahl U., Semb H., and Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 (1998) 190-193
35. Rapp U.R., Fensterle J., Albert S., and Götz R. Raf kinases in lung tumor development. Adv. Enzyme Regul. 43 (2003) 183-195
36. Renyi-Vamos F., Tovari J., Fillinger J., Timar J., Paku S., Kenessey I., Ostoros G., Agocs L., Soltesz I., and Dome B. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin. Cancer Res. 11 (2005) 7344-7353
37. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
38. Rizzino A., Gonda M.A., and Rapp U.R. Dome formation by a retrovirus-induced lung adenocarcinoma cell line. Cancer Res. 42 (1982) 1881-1887
39. Rous P., and Kidd J.G. Conditional neoplasms and subthrehold neoplastic states. J. Exp. Med. 73 (1941) 365-390
40. Schardt J.A., Meyer M., Hartmann C.H., Schubert F., Schmidt-Kittler O., Fuhrmann C., Polzer B., Petronio M., Eils R., and Klein C.A. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8 (2005) 227-239
41. Shibanuma H., Hirano T., Tsuji K., Wu Q., Shrestha B., Konaka C., Ebihara Y., and Kato H. Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer 22 (1998) 85-95
42. Skurk C., Maatz H., Rocnik E., Bialik A., Force T., and Walsh K. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ. Res. 96 (2005) 308-318
43. Solorzano C.C., Baker C.H., Tsan R., Traxler P., Cohen P., Buchdunger E., Killion J.J., and Fidler I.J. Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. Clin. Cancer Res. 7 (2001) 2563-2572
44. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., Chou C.H., Jeng Y.M., Wang M.Y., Chang K.J., et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
45. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7 (1995) 619-627
46. Tinkle C.L., Lechler T., Pasolli H.A., and Fuchs E. Conditional targeting of E-cadherin in skin: Insights into hyperproliferative and degenerative responses. Proc. Natl. Acad. Sci. USA 101 (2004) 552-557
47. Uematsu K., He B., You L., Xu Z., McCormick F., and Jablons D.M. Activation of the Wnt pathway in non small cell lung cancer: Evidence of dishevelled overexpression. Oncogene 16 (2003) 7218-7221
48. You L., He B., Xu Z., Uematsu K., Mazieres J., Mikami I., Reguart N., Moody T.W., Kitajewski J., McCormick F., and Jablons D.M. Inhibition of Wnt-2 -mediated signaling induced programmed cell death in non-small-cell lung cancer cells. Oncogene 12 (2004) 6170-6174